Lobbying client
RESVERLOGIX CORP.
Pharmaceutical
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.
Filings
20
Filed by
2
Reported in-house
—
Reported by firms
$312,500
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2013 to 2019
Filings
4 filings for 2018, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
4th Quarter - Report 4th Quarter 2018
|
CANNAE POLICY GROUP LLC | $37,500 reported |
|
3rd Quarter - Report 3rd Quarter 2018
|
CANNAE POLICY GROUP LLC | $37,500 reported |
|
2nd Quarter - Report 2nd Quarter 2018
|
CANNAE POLICY GROUP LLC | $37,500 reported |
|
1st Quarter - Report 1st Quarter 2018
|
CANNAE POLICY GROUP LLC | $37,500 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| CANNAE POLICY GROUP LLC | 11 | $312,500 |
| TWENTY-FIRST CENTURY GROUP, INC. | 5 | — |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 8 |
| Pharmacy | PHA | 4 |
| Medical/Disease Research/Clinical Labs | MED | 3 |
| Accounting | ACC | 3 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.